Director/PDMR Shareholding

RNS Number : 8270W

GlaxoSmithKline PLC

14 February 2017

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr R G Connor
b)	Position/status	President, Global Manufacturing & Supply
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	The exercise of options over 2,249 Ordinary Shares, granted on 20 February 2007 under the GlaxoSmithKline Share Option Plan.
c)	Price(s) and volume(s)	Price(s) Volume(s) £14.88 2,249
d)	Aggregated information Aggregated volume Price	n/a (single transaction)
e)	Date of the transaction	2017-02-13
f)	Place of the transaction	n/a

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr R G Connor
b)	Position/status	President, Global Manufacturing & Supply
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	The sale of 2,220 Ordinary Shares to satisfy option costs and the tax and NI liability arising following the exercise of options over 2,249 Ordinary Shares granted on 20 February 2007 under the GlaxoSmithKline Share Option Plan.
c)	Price(s) and volume(s)	Price(s) Volume(s) £15.8125 2,220
d)	Aggregated information Aggregated volume Price	n/a (single transaction)
e)	Date of the transaction	2017-02-13
f)	Place of the transaction	London Stock Exchange (XLON)

 

END

 

 

DSHKZLBFDLFZBBD